Want to see IN:WINDLAS full AI Analyst Report?
Windlas Biotech Ltd. (WINDLAS) Ratios
Windlas Biotech Ltd. Ratios
IN:WINDLAS's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:WINDLAS's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.95 | 2.11 | 2.51 | 2.92 | 4.06 |
| Quick Ratio | 1.76 | 1.78 | 2.15 | 2.30 | 3.44 |
| Cash Ratio | 0.01 | 0.00 | 0.03 | 0.03 | 0.01 |
| Solvency Ratio | 0.30 | 0.35 | 0.41 | 0.43 | 0.52 |
| Operating Cash Flow Ratio | 0.32 | 0.27 | 0.63 | 0.50 | 0.10 |
| Short-Term Operating Cash Flow Coverage | 3.40 | 2.51 | 999.63 | 181.99 | 1.61 |
| Net Current Asset Value | $ 3.00B | $ 2.70B | $ 2.55B | $ 2.27B | $ 2.85B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.06 | 0.06 | 0.01 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.06 | 0.06 | 0.01 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.56 | 1.50 | 1.39 | 1.31 | 1.24 |
| Debt Service Coverage Ratio | 2.43 | 2.96 | 59.91 | 49.67 | 7.28 |
| Interest Coverage Ratio | 15.33 | 15.09 | 59.02 | 60.82 | 28.42 |
| Debt to Market Cap | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 |
| Interest Debt Per Share | 19.05 | 17.69 | 2.28 | 2.67 | 3.93 |
| Net Debt to EBITDA | 0.32 | 0.29 | -0.02 | 0.02 | 0.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.14% | 37.90% | 36.33% | 35.45% | 34.65% |
| EBIT Margin | 8.18% | 11.07% | 12.43% | 11.33% | 10.14% |
| EBITDA Margin | 11.59% | 14.76% | 14.57% | 13.75% | 12.76% |
| Operating Profit Margin | 8.18% | 8.70% | 10.37% | 9.39% | 8.69% |
| Pretax Profit Margin | 9.62% | 10.50% | 12.26% | 11.17% | 9.83% |
| Net Profit Margin | 7.35% | 8.03% | 9.25% | 8.35% | 8.22% |
| Continuous Operations Profit Margin | 7.35% | 8.03% | 9.25% | 8.35% | 8.22% |
| Net Income Per EBT | 76.41% | 76.47% | 75.48% | 74.73% | 83.59% |
| EBT Per EBIT | 117.54% | 120.62% | 118.20% | 119.02% | 113.13% |
| Return on Assets (ROA) | 7.32% | 8.02% | 9.29% | 8.06% | 7.76% |
| Return on Equity (ROE) | 11.44% | 12.06% | 12.93% | 10.60% | 9.65% |
| Return on Capital Employed (ROCE) | 12.62% | 12.94% | 14.35% | 11.75% | 10.14% |
| Return on Invested Capital (ROIC) | 9.13% | 9.34% | 10.79% | 8.74% | 8.35% |
| Return on Tangible Assets | 7.38% | 8.09% | 9.36% | 8.08% | 7.77% |
| Earnings Yield | 4.29% | 2.87% | 5.18% | 8.74% | 8.85% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.98 | 4.55 | 4.59 | 4.37 | 4.18 |
| Payables Turnover | 3.10 | 2.82 | 3.04 | 3.76 | 4.79 |
| Inventory Turnover | 11.97 | 5.80 | 6.44 | 4.41 | 5.16 |
| Fixed Asset Turnover | 3.40 | 3.42 | 3.49 | 4.16 | 4.71 |
| Asset Turnover | 1.00 | 1.00 | 1.00 | 0.97 | 0.94 |
| Working Capital Turnover Ratio | 3.11 | 2.84 | 2.56 | 1.96 | 2.39 |
| Cash Conversion Cycle | 4.67 | 13.74 | 16.29 | 69.14 | 81.80 |
| Days of Sales Outstanding | 91.81 | 80.15 | 79.48 | 83.54 | 87.26 |
| Days of Inventory Outstanding | 30.49 | 62.95 | 56.69 | 82.77 | 70.77 |
| Days of Payables Outstanding | 117.62 | 129.36 | 119.88 | 97.17 | 76.22 |
| Operating Cycle | 122.30 | 143.11 | 136.17 | 166.31 | 158.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 48.23 | 32.61 | 52.38 | 28.18 | 4.45 |
| Free Cash Flow Per Share | 16.06 | 7.65 | 34.26 | -4.59 | -2.77 |
| Dividend Paid and CapEx Coverage Ratio | 1.27 | 1.07 | 2.37 | 0.78 | 0.62 |
| Capital Expenditure Coverage Ratio | 1.50 | 1.31 | 2.89 | 0.86 | 0.62 |
| Operating Cash Flow Coverage Ratio | 2.88 | 2.09 | 29.93 | 12.21 | 1.38 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.09 | 0.17 | 0.12 | 0.02 |
| Free Cash Flow Yield | 2.18% | 0.75% | 6.34% | -2.04% | -1.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 23.31 | 34.83 | 19.32 | 11.44 | 11.30 |
| Price-to-Sales (P/S) Ratio | 1.71 | 2.80 | 1.79 | 0.95 | 0.93 |
| Price-to-Book (P/B) Ratio | 2.67 | 4.20 | 2.50 | 1.21 | 1.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 45.88 | 132.80 | 15.77 | -49.11 | -75.88 |
| Price-to-Operating Cash Flow Ratio | 15.28 | 31.15 | 10.32 | 8.00 | 47.16 |
| Price-to-Earnings Growth (PEG) Ratio | 2.80 | 8.12 | 0.46 | 1.90 | 0.10 |
| Enterprise Value Multiple | 15.11 | 19.23 | 12.25 | 6.96 | 7.38 |
| Enterprise Value | 15.83B | 21.56B | 11.22B | 4.89B | 4.37B |
| EV to EBITDA | 15.11 | 19.23 | 12.25 | 6.96 | 7.38 |
| EV to Sales | 1.75 | 2.84 | 1.78 | 0.96 | 0.94 |
| EV to Free Cash Flow | 46.87 | 134.81 | 15.75 | -49.25 | -76.95 |
| EV to Operating Cash Flow | 15.60 | 31.62 | 10.30 | 8.02 | 47.82 |
| Tangible Book Value Per Share | 272.91 | 238.67 | 214.13 | 185.24 | 192.17 |
| Shareholders’ Equity Per Share | 276.19 | 241.91 | 216.28 | 185.93 | 192.60 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.24 | 0.25 | 0.25 | 0.16 |
| Revenue Per Share | 429.90 | 363.45 | 302.30 | 235.99 | 226.07 |
| Net Income Per Share | 31.60 | 29.17 | 27.97 | 19.70 | 18.58 |
| Tax Burden | 0.76 | 0.76 | 0.75 | 0.75 | 0.84 |
| Interest Burden | 1.18 | 0.95 | 0.99 | 0.99 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 |
| SG&A to Revenue | 0.10 | 0.03 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.53 | 1.12 | 1.87 | 1.07 | 0.20 |
Currency in INR